KRISHI
ICAR RESEARCH DATA REPOSITORY FOR KNOWLEDGE MANAGEMENT
(An Institutional Publication and Data Inventory Repository)
"Not Available": Please do not remove the default option "Not Available" for the fields where metadata information is not available
"1001-01-01": Date not available or not applicable for filling metadata infromation
"1001-01-01": Date not available or not applicable for filling metadata infromation
Please use this identifier to cite or link to this item:
http://krishi.icar.gov.in/jspui/handle/123456789/78031
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Thangamalai R, Kandasamy K, Sukumarn SV, Reddy N, Singh V, Choudhury S, Parida S, Singh TU, Boobalan R, Mishra SK | en_US |
dc.date.accessioned | 2023-06-05T09:00:08Z | - |
dc.date.available | 2023-06-05T09:00:08Z | - |
dc.date.issued | 2014-01-08 | - |
dc.identifier.citation | Thangamalai R, Kandasamy K, Sukumarn SV, Reddy N, Singh V, Choudhury S, Parida S, Singh TU, Boobalan R, Mishra SK. Atorvastatin prevents sepsis-induced downregulation of myocardial β1-adrenoceptors and decreased cAMP response in mice. Shock. 2014 May;41(5):406-12. doi: 10.1097/SHK.0000000000000138. PMID: 24430540. | en_US |
dc.identifier.issn | Not Available | - |
dc.identifier.uri | http://krishi.icar.gov.in/jspui/handle/123456789/78031 | - |
dc.description | Not Available | en_US |
dc.description.abstract | Impaired cardiac "-adrenoceptor signaling is an important cause of sepsis-induced myocardial depression in man and experimental animals. We examined the effect of atorvastatin (ATR) pretreatment on myocardial "1-adrenoceptor ("1-AR) expressions and postYreceptor signaling in a mouse model of sepsis (cecal ligation and puncture [CLP]). After 20 T 2 h of surgery, hearts were isolated for the measurement of left ventricular functions (left ventricular developed pressure, dp/ dtmax and dp/dtmin) using Langendorff setup. Western blot was used to determine "1-AR and G proteinYcoupled receptor kinase 2 protein expressions. Real-time polymerase chain reaction was done to determine "1-AR mRNA expression. Atorvastatin prevented sepsis-induced decrease in left ventricular functions, such as left ventricular developed pressure (CLP 75.90 T 0.53 vs. ATR 100.24 T 1.64 mmHg), dp/dtmax (CLP 3,742 T 71 vs. ATR 4,291 T 88 mmHg/s), and dp/dtmin (CLP j1,010 T 24 vs. ATR j1,346 T 84 mmHg/s). Associated with functional impairments, sepsis decreased both myocardial "1-AR protein and mRNA expressions by 52% T 9% and 62% T 7%, respectively. However, ATR treatment of CLP mice (ATR) preserved "1-AR protein (96% T 11%) and mRNA (88% T 14%) expressions comparable to sham-operated level. Furthermore, it not only attenuated sepsis-induced decrease in basal cardiac adenosine 3¶,5¶-cyclic monophosphate content (CLP 1.30 T 0.27 vs. ATR 6.30 T 0.67 pmol/mg protein), but also prevented its refractoriness to dobutamine stimulation (CLP 1.72 T 0.27 vs. ATR 10.83 T 1.37 pmol/mg protein). Atorvastatin also inhibited sepsis-induced increase in cardiac G proteinYcoupled receptor kinase 2 protein expression (CLP 1.73 T 0.18-fold vs. ATR 1.10 T 0.18-fold), protein kinase A activity (CLP 1.12 T 0.14 vs. ATR 0.66 T 0.08 U/mg protein) and plasma catecholamines (CLP 138 T 22 vs. ATR 59 T 2 pg/mL). In conclusion, ATR seems to improve left ventricular functions in vitro through the preservation of "1-AR signaling in sepsis | en_US |
dc.description.sponsorship | Not Available | en_US |
dc.language.iso | English | en_US |
dc.publisher | Lippincott Williams & Wilkins | en_US |
dc.relation.ispartofseries | Not Available; | - |
dc.subject | "b1-adrenoceptor, catecholamines, GRK2, heart, sepsis, statin | en_US |
dc.title | Atorvastatin prevents sepsis-induced downregulation of myocardial β1-adrenoceptors and decreased cAMP response in mice | en_US |
dc.title.alternative | Not Available | en_US |
dc.type | Article | en_US |
dc.publication.projectcode | Not Available | en_US |
dc.publication.journalname | Shock | en_US |
dc.publication.volumeno | Not Available | en_US |
dc.publication.pagenumber | Not Available | en_US |
dc.publication.divisionUnit | Division of Pharmacology and Toxicology, ICAR-IVRI | en_US |
dc.publication.sourceUrl | https://doi.org/10.1097/shk.0000000000000138 | en_US |
dc.publication.authorAffiliation | ICAR::Indian Veterinary Research Institute | en_US |
dc.ICARdataUseLicence | http://krishi.icar.gov.in/PDF/ICAR_Data_Use_Licence.pdf | en_US |
dc.publication.journaltype | Included NAAS journal list | en_US |
dc.publication.naasrating | 9.53 | en_US |
dc.publication.impactfactor | 3.53 | en_US |
Appears in Collections: | AS-IVRI-Publication |
Files in This Item:
There are no files associated with this item.
Items in KRISHI are protected by copyright, with all rights reserved, unless otherwise indicated.